{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:39:01Z","timestamp":1792273141654,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Science and Technology Development Fund, Macau SAR","award":["File no. 0002\/2025\/NRP and 0037\/2025\/RIB1"],"award-info":[{"award-number":["File no. 0002\/2025\/NRP and 0037\/2025\/RIB1"]}]},{"name":"University of Macau Multi-Year Research Grant","award":["MYRG-GRG2024-00123-ICMS-UMDF"],"award-info":[{"award-number":["MYRG-GRG2024-00123-ICMS-UMDF"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"DOI":"10.1007\/s13346-026-02195-6","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:26:47Z","timestamp":1785943607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dissecting corneal drug permeability under experimental variability and drug cold-start challenges via hybrid machine learning"],"prefix":"10.1007","author":[{"given":"Shuya","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8052-4773","authenticated-orcid":false,"given":"Defang","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"2195_CR1","unstructured":"Organization, WH, World report on vision, in World report on vision. 2019."},{"key":"2195_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0039-6257(93)90141-S","volume":"37","author":"A Urtti","year":"1993","unstructured":"Urtti A, Salminen L. Minimizing systemic absorption of topically administered ophthalmic drugs. Surv Ophthalmol. 1993;37:435\u201356.","journal-title":"Surv Ophthalmol"},{"key":"2195_CR3","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3109\/03639045.2012.736515","volume":"39","author":"D Achouri","year":"2013","unstructured":"Achouri D, Alhanout K, Piccerelle P, Andrieu V. Recent advances in ocular drug delivery. Drug Dev Ind Pharm. 2013;39:1599\u2013617.","journal-title":"Drug Dev Ind Pharm"},{"key":"2195_CR4","doi-asserted-by":"publisher","first-page":"432376","DOI":"10.1155\/2015\/432376","volume":"2015","author":"V Dave","year":"2015","unstructured":"Dave V, Paliwal S, Yadav S, Sharma S. Effect of in vitro transcorneal approach of aceclofenac eye drops through excised goat, sheep, and buffalo corneas. ScientificWorldJournal. 2015;2015:432376.","journal-title":"ScientificWorldJournal"},{"key":"2195_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ejpb.2016.07.009","volume":"107","author":"S Pescina","year":"2016","unstructured":"Pescina S, Carra F, Padula C, Santi P, Nicoli S. Effect of pH and penetration enhancers on cysteamine stability and trans-corneal transport. Eur J Pharm Biopharm. 2016;107:171\u20139.","journal-title":"Eur J Pharm Biopharm"},{"key":"2195_CR6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","volume":"6","author":"V Agrahari","year":"2016","unstructured":"Agrahari V, Mandal A, Agrahari V, Trinh HM, Joseph M, Ray A, et al. A comprehensive insight on ocular pharmacokinetics. Drug Deliv Transl Res. 2016;6:735\u201354.","journal-title":"Drug Deliv Transl Res"},{"key":"2195_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/pharmaceutics11070321","volume":"11","author":"RV Moiseev","year":"2019","unstructured":"Moiseev RV, Morrison PWJ, Steele F, Khutoryanskiy VV. Penetration enhancers in ocular drug delivery. Pharmaceutics. 2019;11:321.","journal-title":"Pharmaceutics"},{"key":"2195_CR8","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S1461-5347(98)00100-X","volume":"1","author":"HE Junginger","year":"1998","unstructured":"Junginger HE, Verhoef JC. Macromolecules as safe penetration enhancers for hydrophilic drugs - A fiction? Pharm Sci Technol Today. 1998;1:370\u20136.","journal-title":"Pharm Sci Technol Today"},{"key":"2195_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/156720106776359186","volume":"3","author":"Y Sultana","year":"2006","unstructured":"Sultana Y, Jain R, Aqil M, Ali A. Review of ocular drug delivery. Curr Drug Deliv. 2006;3:207\u201317.","journal-title":"Curr Drug Deliv"},{"key":"2195_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-4274(01)00261-2","volume":"122","author":"S Burgalassi","year":"2001","unstructured":"Burgalassi S, Chetoni P, Monti D, Saettone MF. Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines. Toxicol Lett. 2001;122:1\u20138.","journal-title":"Toxicol Lett"},{"key":"2195_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijpharm.2014.06.007","volume":"472","author":"PW Morrison","year":"2014","unstructured":"Morrison PW, Khutoryanskiy VV. Enhancement in corneal permeability of riboflavin using calcium sequestering compounds. Int J Pharm. 2014;472:56\u201364.","journal-title":"Int J Pharm"},{"key":"2195_CR12","first-page":"415","volume":"12","author":"SH Chung","year":"2006","unstructured":"Chung SH, Lee SK, Cristol SM, Lee ES, Lee DW, Seo KY, et al. Impact of short-term exposure of commercial eyedrops preserved with benzalkonium chloride on precorneal mucin. Mol Vis. 2006;12:415\u201321.","journal-title":"Mol Vis"},{"key":"2195_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1081\/DDC-120002997","volume":"28","author":"IP Kaur","year":"2002","unstructured":"Kaur IP, Smitha R. Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery. Drug Dev Ind Pharm. 2002;28:353\u201369.","journal-title":"Drug Dev Ind Pharm"},{"key":"2195_CR14","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ijpharm.2017.06.075","volume":"529","author":"I Rodr\u00edguez","year":"2017","unstructured":"Rodr\u00edguez I, V\u00e1zquez JA, Pastrana L, Khutoryanskiy VV. Enhancement and inhibition effects on the corneal permeability of timolol maleate: Polymers, cyclodextrins and chelating agents. Int J Pharm. 2017;529:168\u201377.","journal-title":"Int J Pharm"},{"key":"2195_CR15","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s13346-015-0275-6","volume":"6","author":"P Agarwal","year":"2016","unstructured":"Agarwal P, Rupenthal ID. In vitro and ex vivo corneal penetration and absorption models. Drug Deliv Transl Res. 2016;6:634\u201347.","journal-title":"Drug Deliv Transl Res"},{"key":"2195_CR16","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.3390\/pharmaceutics15061646","volume":"15","author":"CP Santana","year":"2023","unstructured":"Santana CP, Matter BA, Patil MA, Silva-Cunha A, Kompella UB. Corneal permeability and uptake of twenty-five drugs: species comparison and quantitative structure-permeability relationships. Pharmaceutics. 2023;15:1646.","journal-title":"Pharmaceutics"},{"key":"2195_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/17425247.2018.1406918","volume":"15","author":"SK Li","year":"2018","unstructured":"Li SK, Hao J. Transscleral passive and iontophoretic transport: theory and analysis. Expert Opin Drug Deliv. 2018;15:283\u201399.","journal-title":"Expert Opin Drug Deliv"},{"key":"2195_CR18","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1007\/s11095-010-0132-8","volume":"27","author":"H Kidron","year":"2010","unstructured":"Kidron H, Vellonen KS, del Amo EM, Tissari A, Urtti A. Prediction of the corneal permeability of drug-like compounds. Pharm Res. 2010;27:1398\u2013407.","journal-title":"Pharm Res"},{"key":"2195_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejps.2018.03.034","volume":"119","author":"E Ramsay","year":"2018","unstructured":"Ramsay E, Del Amo EM, Toropainen E, Tengvall-Unadike U, Ranta VP, Urtti A, et al. Corneal and conjunctival drug permeability: Systematic comparison and pharmacokinetic impact in the eye. Eur J Pharm Sci. 2018;119:83\u201389.","journal-title":"Eur J Pharm Sci"},{"key":"2195_CR20","doi-asserted-by":"crossref","unstructured":"Wang, N, Wang W., Zhong H., Ouyang D., Introduction to Computational Pharmaceutics, in Exploring Computational Pharmaceutics \u2010 AI and Modeling in Pharma 4.0. 2024. p. 1\u20139.","DOI":"10.1002\/9781119987260.ch1"},{"key":"2195_CR21","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1021\/acs.molpharmaceut.4c00946","volume":"22","author":"Z Wu","year":"2025","unstructured":"Wu Z, Wang N, Ye Z, Xu H, Chan G, Ouyang D. FormulationBCS: A machine learning platform based on diverse molecular representations for biopharmaceutical classification system (BCS) class prediction. Mol Pharm. 2025;22:330\u201342.","journal-title":"Mol Pharm"},{"key":"2195_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jconrel.2024.12.043","volume":"378","author":"N Wang","year":"2025","unstructured":"Wang N, Dong J, Ouyang D. AI-directed formulation strategy design initiates rational drug development. J Control Release. 2025;378:619\u201336.","journal-title":"J Control Release"},{"key":"2195_CR23","doi-asserted-by":"publisher","first-page":"114418","DOI":"10.1016\/j.jconrel.2025.114418","volume":"389","author":"P Xiong","year":"2026","unstructured":"Xiong P, Zhu J, Zhong H, Wang W, Wang N, Lu T, et al. FormulationLAI: A physiology-based machine learning framework for accelerated development of long-acting injectable formulations. J Control Release. 2026;389:114418.","journal-title":"J Control Release"},{"key":"2195_CR24","doi-asserted-by":"publisher","first-page":"114772","DOI":"10.1016\/j.addr.2023.114772","volume":"196","author":"N Wang","year":"2023","unstructured":"Wang N, Zhang Y, Wang W, Ye Z, Chen H, Hu G, et al. How can machine learning and multiscale modeling benefit ocular drug development? Adv Drug Deliv Rev. 2023;196:114772.","journal-title":"Adv Drug Deliv Rev"},{"key":"2195_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1089\/jop.2021.0069","volume":"38","author":"TK Karami","year":"2022","unstructured":"Karami TK, Hailu S, Feng S, Graham R, Gukasyan HJ. Eyes on Lipinski\u2019s rule of five: A new \u201cRule of Thumb\u201d for physicochemical design space of ophthalmic drugs. J Ocul Pharmacol Ther. 2022;38:43\u201355.","journal-title":"J Ocul Pharmacol Ther"},{"key":"2195_CR26","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1021\/js9802594","volume":"87","author":"MR Prausnitz","year":"1998","unstructured":"Prausnitz MR, Noonan JS. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci. 1998;87:1479\u201388.","journal-title":"J Pharm Sci"},{"key":"2195_CR27","unstructured":"Food and Drug Administration (FDA). [cited 2026; Available from: https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/national-drug-code-directory."},{"key":"2195_CR28","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","volume":"60","author":"JJ Irwin","year":"2020","unstructured":"Irwin JJ, Tang KG, Young J, Dandarchuluun C, Wong BR, Khurelbaatar M, et al. ZINC20\u2014A free ultralarge-scale chemical database for ligand discovery. Journal of Chemical Information and Modeling. 2020;60:6065\u201373.","journal-title":"Journal of Chemical Information and Modeling"},{"key":"2195_CR29","first-page":"4","volume":"1","author":"G Landrum","year":"2013","unstructured":"Landrum G. Rdkit documentation. Release. 2013;1:4.","journal-title":"Release"},{"key":"2195_CR30","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/pharmaceutics17040447","volume":"17","author":"G Santos","year":"2025","unstructured":"Santos G, Delgado E, Silva B, Braz BS, Gon\u00e7alves L. Topical ocular drug delivery: the impact of permeation enhancers. Pharmaceutics. 2025;17:447.","journal-title":"Pharmaceutics"},{"key":"2195_CR31","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: Machine learning in Python. J Mach Learn Res. 2011;12:2825\u201330.","journal-title":"J Mach Learn Res"},{"key":"2195_CR32","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41586-024-08328-6","volume":"637","author":"N Hollmann","year":"2025","unstructured":"Hollmann N, M\u00fcller S, Purucker L, Krishnakumar A, K\u00f6rfer M, Hoo SB, et al. Accurate predictions on small data with a tabular foundation model. Nature. 2025;637:319\u201326.","journal-title":"Nature"},{"key":"2195_CR33","unstructured":"Lundberg, SM, Lee S-I. A unified approach to interpreting model predictions. In: Proceedings of the 31st International Conference on Neural Information Processing Systems (NIPS'17); 2017 Dec 4-9; 2017:4768-4777."},{"key":"2195_CR34","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1021\/mp3005963","volume":"10","author":"PW Morrison","year":"2013","unstructured":"Morrison PW, Connon CJ, Khutoryanskiy VV. Cyclodextrin-mediated enhancement of riboflavin solubility and corneal permeability. Mol Pharm. 2013;10:756\u201362.","journal-title":"Mol Pharm"},{"key":"2195_CR35","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/cpt.3732","volume":"118","author":"W Wang","year":"2025","unstructured":"Wang W, Wang N, Wu Y, Ye Z, Zhao L, Chen X, et al. An integrated AI-PBPK platform for predicting drug in vivo fate and tissue distribution in human and inter-species extrapolation. Clin Pharmacol Ther. 2025;118:865\u201375.","journal-title":"Clin Pharmacol Ther"},{"key":"2195_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejps.2012.05.007","volume":"47","author":"C Loch","year":"2012","unstructured":"Loch C, Zakelj S, Kristl A, Nagel S, Guthoff R, Weitschies W, et al. Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyes. Eur J Pharm Sci. 2012;47:131\u20138.","journal-title":"Eur J Pharm Sci"},{"key":"2195_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/2040622313511286","volume":"5","author":"D Sambhara","year":"2014","unstructured":"Sambhara D, Aref AA. Glaucoma management: relative value and place in therapy of available drug treatments. Ther Adv Chronic Dis. 2014;5:30\u201343.","journal-title":"Ther Adv Chronic Dis"},{"key":"2195_CR38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0378-5173(96)04663-7","volume":"142","author":"MF Saettone","year":"1996","unstructured":"Saettone MF, Chetoni P, Cerbai R, Mazzanti G, Braghiroli L. Evaluation of ocular permeation enhancers: In vitro effects on corneal transport of four \u03b2-blockers, and in vitro\/in vivo toxic activity. Int J Pharm. 1996;142:103\u201313.","journal-title":"Int J Pharm"},{"key":"2195_CR39","doi-asserted-by":"publisher","first-page":"115764","DOI":"10.1016\/j.addr.2025.115764","volume":"229","author":"N Wang","year":"2026","unstructured":"Wang N, Zhong H, Xiong P, Zhu J, Ouyang D. Quality by computational design: harnessing ai to advance rational drug development. Adv Drug Deliv Rev. 2026;229:115764.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"2195_CR40","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/j.apsb.2025.09.022","volume":"16","author":"Y Wu","year":"2026","unstructured":"Wu Y, Wang N, Xiong P, Wang R, Deng J, Ouyang D. Artificial intelligence for drug delivery: Yesterday, today and tomorrow. Acta Pharm Sin B. 2026;16(4):2068\u201392.","journal-title":"Acta Pharm Sin B"},{"key":"2195_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1208\/s12248-024-01001-w","volume":"27","author":"H Zhong","year":"2024","unstructured":"Zhong H, Lu T, Wang R, Ouyang D. Quantitative analysis of physical stability mechanisms of amorphous solid dispersions by molecular dynamic simulation. AAPS J. 2024;27:9.","journal-title":"AAPS J"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02195-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02195-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02195-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:26:49Z","timestamp":1785943609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02195-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":41,"alternative-id":["2195"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02195-6","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"18 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No ethical approval is required for this study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All the authors read and approved the final version of the manuscript.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"During the preparation of this work the authors used ChatGPT in order to improve language. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":4,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Ethics"}}]}}